Scotiabank Maintains Buy Rating on Amgen with $500 Target Price

Scotiabank analyst Louise Chen has maintained her buy rating on Amgen (AMGN.US), keeping her target price at $500. According to TipRanks data, Chen's success rate over the past year is 54.1%, with an average return of 7.2%. This information is provided by TipRanks as a neutral analysis tool and should not be considered investment advice.

TipRanks calculates analyst performance based on their recommendations' impact on a virtual portfolio. Chen's success rate is the number of her successful ratings divided by her total number of ratings over the past year. A successful rating occurs when TipRanks' virtual portfolio earns a positive return from the stock.